A Phase I Study of TQ-B3234 on Tolerance and Pharmacokinetics

NCT02996838 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: TQ-B3234

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.